Skip to content

Talphera, Inc. TLPH Debt-to-equity

Discontinued — last reported Q1 '23

Debt-to-equity at other companies

Baxter International logo
Baxter InternationalBAX
0.0×
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
8.4×+6.9×
Royalty Pharma logo
Royalty PharmaRPRX
0.9×+0.1×
PTH
Pelthos Therapeutics Inc.PTHS
0.8×
XOMA Corporation logo
XOMA CorporationXOMA
1.3×0.0×
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
0.2×+0.1×

Other financials

Income statement

See full
Revenue--100%
Gross profit-$1.9M-52.7%
Operating income-$3.9M-35.4%
Net income-$2.6M+1.4%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Cash & equivalents$3.8M-29.0%
Total debt$3.4M-79.7%
Total equity$18.5M+230%
Total assets$30.2M+101%

Cash flow

See full
Operating cash flow-$3.4M+2.0%
CapEx-
Free cash flow-$2.3M+42.9%

Valuation

See full
Market cap$53.46M+493%
P/S53,456.6×+53,123×

Profitability

See full
Gross margin-127.7%-136pp
Operating margin-1,451,600%-1,507,145pp
Net margin-1,425,300%-1,471,200pp
FCF margin-5,116.7%-6,779pp

Returns & leverage

See full
Return on equity-118.4%+15.4pp
Current ratio5.3×+2.2×

Where this comes from

Calculated from Talphera, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Talphera, Inc.’s 10-Q, filed May 10, 2023, on SEC EDGAR. View the filing →

Ask your AI about Talphera, Inc.'s debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Talphera, Inc.'s debt-to-equity?
Talphera, Inc. (TLPH) reported debt-to-equity of 0.2× in Q1 2023.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.